MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-MP-10-0027479
Nd Pharma Private Limited
Nd Pharma Private Limited - mining in New Delhi, Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹29.93 Cr
▼ 9% YoY
Net profit · FY 2024
₹5.68 Cr
Net margin 19%
EBITDA · FY 2024
₹8.16 Cr
EBITDA margin 27.3%
Authorised capital
₹1 Cr
Registered with MCA
Paid-up capital
₹1 Cr
Issued & subscribed
Open charges
₹10 Cr
Secured borrowings
Company age
16 yrs
Est. 2010
Directors on board
2
As per MCA filings
About Nd Pharma Private Limited
Data last updated:
Nd Pharma Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the other mining and quarrying segment of the mining sector. It was incorporated on 16 August 2010 and has been in existence for over 16 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24232DL2010PTC207121. Its GSTIN is 09AAECN4723E1ZL (Uttar Pradesh). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹1 Cr and a paid-up capital of ₹1 Cr. It is led by directors Chander Shekhar Chaurasia and Aditya Chopra.
Its last annual general meeting (AGM) was held on 29 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 13/21 Second Floor Adarsh Bhawan, Punjab.
As per the financials filed for FY 2024, the company reported a revenue of ₹29.93 Cr, a decline of 9% compared to the previous year. For the same year it recorded a net profit of ₹5.68 Cr (net margin 19%) and EBITDA of ₹8.16 Cr (EBITDA margin 27.3%). Revenue has grown at a compounded annual rate (CAGR) of 968% over three years.
As per MCA filings, the company has open charges of ₹10 Cr on record. Court records list 5 cases involving the company, including 3 filed by the company and 2 filed against it; 4 cases are pending.
Nd Pharma Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-MP-10-0027479). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U24232DL2010PTC207121
Registration Number 207121
Incorporation Date 16 August 2010
ROC Delhi
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-MP-10-0027479
Recognitions & Rankings of Nd Pharma
Contact details
Nd Pharma Private Limited's registered office is in New Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address13/21 Second Floor Adarsh Bhawan, Cghs Punjabi Bagh Extn, New Delhi, Delhi, India – 110026
- IndustryMining, Other Mining & Quarrying
To see the full contact details of Nd Pharma Private Limited, buy the company report.
Comprehensive company report
Nd Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Nd Pharma is mining and quarrying. In detail, this covers other mining & quarrying activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| B | Mining and quarrying | B4 | Other Mining & Quarrying Activities |
To see the full business activity and turnover split of Nd Pharma Private Limited, buy the company report.
Financials of Nd Pharma Private Limited
FY 2024 filings availableNd Pharma Private Limited reported revenue of ₹29.93 Cr (down 9% YoY) for FY 2024.
Revenue · FY 2024
₹29.93 Cr ▼ 9%
Net profit · FY 2024
₹5.68 Cr margin 19%
EBITDA · FY 2024
₹8.16 Cr margin 27.3%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 9%
3 years · compounded
▲ 968%
EBITDA CAGR growth
1 year
▲ 58%
3 years · compounded
▲ 404%
5 years · compounded
▲ 829%
Revenue fell 9% in the latest year, but over three years it has grown at a compounded annual rate (CAGR) of 968%. EBITDA rose 58% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹8.16 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹5.68 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 27.3% | ||||
| Net Profit Margin | 19% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Nd Pharma Private Limited, buy the company report.
Board of directors of Nd Pharma Private Limited
Nd Pharma has 2 current directors and 9 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Chander Shekhar Chaurasia | Director | 03 Feb 2025 | 1 Years 9 Months | Current |
| Aditya Chopra Also directs: Nature Serenity Estates LLP, Euphoria Khanij Private Limited, DD Khanij Private Limited and 3 more | Director | 20 Jun 2023 | 3 Years 4 Months | Current |
Peer comparison
Nd Pharma Private Limited is compared with the 3 companies closest to it by revenue in the Metals and Minerals industry (Mining), with the same principal business activity (other mining & quarrying activities), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Earth Coal Private Limited | ₹30.17 Cr (FY 2024) | -20.0% | Nagpur, Maharashtra, India | |||
| Nd Pharma Private Limitedthis company | ₹29.93 Cr (FY 2024) | ₹5.68 Cr | 19% | -9.0% | New Delhi, Delhi, India | |
| N M Dubash Stone & Lime Company Pvt Ltd | ₹29.59 Cr (FY 2025) | 18.0% | Kolkata, West Bengal, India | |||
| Kakatiya Minerals Private Limited | ₹29.35 Cr (FY 2025) | -84.0% | Hyderabad, Telangana, India |
To see the full peer comparison of Nd Pharma Private Limited, buy the company report.
Auditor
Nd Pharma Private Limited is audited by JAIN AGRAWAL S & ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| JAIN AGRAWAL S & ASSOCIATES | FY 2023 | 029432C |
Shareholding
The shareholding of Nd Pharma Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Nd Pharma Private Limited, buy the company report.
Charges & borrowings
Open charges
₹10 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 09 May 2022 | 100583198 | Hdfc Bank Limited | ₹10 Cr | Open |
To see the full charge records of Nd Pharma Private Limited, buy the company report.
Total charge records: 1 View all charges
Legal cases
Nd Pharma Private Limited has 5 court cases on record: 3 filed by Nd Pharma, 2 filed against it. 4 cases are pending and 1 is disposed.
Total cases
5
Filed by the company
3
Filed against the company
2
Pending
4
Disposed
1
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 2 | 2 | 2 |
| High courts | 2 | 0 | 1 |
| Supreme Court | 1 | 0 | 1 |
Cases on record (5 of 5)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, New Delhi, Delhi | Court case (TRAFFIC CHALLAN) | Filed against the company by State | Pending |
| District court, South West, Delhi | Civil suit | Filed against the company by State | Pending |
| Supreme Court | Appeal | Filed by the company against Union of India | Pending |
| Allahabad High Court | Writ petition | Filed by the company against State of U.P. and 2 Others | Pending |
| High Court, UTTARPRADESH | Writ petition | Filed by the company against State of U.P. and 2 Others | Disposed |
To see the full case history of Nd Pharma Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Nd Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Nd Pharma has 2 GST registrations: 2 active.
Total GSTINs
2
Active
2
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAECN4723E1ZL | Uttar Pradesh | Active | 18 Jan 2018 |
| 23AAECN4723E1ZV | Madhya Pradesh | Active | 18 Aug 2020 |
To see the full GST registrations and return filing status of Nd Pharma Private Limited, buy the company report.
Recent activity
Nd Pharma Private Limited has 11 board changes on record since 2014: 2 appointments and 9 cessations. The latest: Chander Shekhar Chaurasia was appointed as Director on 03 Feb 2025.
Charges
A charge with Hdfc Bank Limited of Rs. 10.00 Cr registered on 09 May 2022 with Charge ID 100583198 was modified on 12 May 2025.
Appointed
Chander Shekhar Chaurasia was appointed as Director.
AGM
Nd Pharma Private Limited last Annual general meeting of members was held on 29 Sep 2024 as per latest MCA records.
Filing
Nd Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi.
Appointed
Aditya Chopra was appointed as Director.
Ceased
Heera Lal Kushwaha ceased to be Director.
Ceased
Rasmeet Singh Malhotra ceased to be Director.
Ceased
Sanjay Chaurasia ceased to be Director.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 10.00 Cr with Charge ID 100583198 was registered on 09 May 2022.
Ceased
Vishakha Jalan Chaurasia ceased to be Director.
Ceased
Himanshu Meena ceased to be Director.
Ceased
Satyendra Singh Pawar ceased to be Director.
4 earlier events are in the company report.
Frequently asked questions
Nd Pharma is an active private limited company based in New Delhi, Delhi, India. The company works in other mining and quarrying, within the mining industry. It was incorporated on 16 August 2010 (16+ years old) and is registered under CIN U24232DL2010PTC207121.
Nd Pharma has 2 current directors:
- Chander Shekhar Chaurasia - Director
- Aditya Chopra - Director
The latest financial statements of Nd Pharma on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 29 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Nd Pharma is 09AAECN4723E1ZL, registered in Uttar Pradesh. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 23AAECN4723E1ZV (Madhya Pradesh).
The CIN (Corporate Identification Number) of Nd Pharma is U24232DL2010PTC207121. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Nd Pharma has 5 court cases on record: 3 filed by the company and 2 filed against it. 4 are pending. Most are in the district courts.
Nd Pharma was incorporated on 16 August 2010, making it 16+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Nd Pharma by revenue are Earth Coal Private Limited, N M Dubash Stone & Lime Company Pvt Ltd, Kakatiya Minerals Private Limited, all in the Metals and Minerals industry (Mining), with the same principal business activity (other mining & quarrying activities).
Chander Shekhar Chaurasia was appointed as Director on 03 Feb 2025. Aditya Chopra was appointed as Director on 20 Jun 2023. Heera Lal Kushwaha ceased to be Director on 26 May 2023. Nd Pharma has 11 board changes on record in total.
Yes, Nd Pharma is registered as a small enterprise under Udyam registration (number: UDYAM-MP-10-0027479).
The registered office of Nd Pharma is at 1321 Second Floor Adarsh Bhawan, Cghs Punjabi Bagh Extn, New Delhi, Delhi, India – 110026.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages